240
Views
47
CrossRef citations to date
0
Altmetric
Research Article

Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use

&
Pages 523-538 | Received 12 Apr 2005, Accepted 04 Feb 2006, Published online: 08 Oct 2008

References

  • Ali H, Lier JEV. Metal complexes as Photo and Radiosensitizers. Chemical Society Review 1999; 99: 2379–2450
  • Argawal LM, Cley ME, Harley EJ, Evans HH, Antunes AR, Olenick NL. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Research 1991; 51: 5993–5996
  • Barratt GM. Colloidal drug carriers: Achievements and perspectives. Cellular & Molecular Life 2003; 60: 21–37
  • Bilati U, Allemann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. European Journal of Pharmaceutical Sciences 2005; 24: 67–75
  • Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chemical Society Reviews 1995; 210: 19–33
  • Calvo P, Vila-Jato MJ, Alonso MJ. Comparative in vitro evaluation of colloids systems, nanoparticles, nanocapsules and nanoemulsions as ocular drug carrier. Journal of Pharmaceutical Sciences 1996; 85: 530–536
  • Castano AP, Demidova T, Hamblim MR. Mechanisms in photodynamic therapy: Party one-photosensitizers, photochemistry and cellular localization. Photodiagnosis and Photodynamic Therapy. 2005; 2: 91–106
  • Cuccovia M, Quina FH, Chaimovich H. A remarkable enhancement of the rate of the ester thiolysis by synthetic amphiphile vesicles. Tetrahedron 1982; 38: 917–920
  • Davies MJ. Singlet oxygen-mediated damage to proteins and its consequences. Biochemical & Biophysical Research Communications 2003; 305: 761–770
  • Derycke ASL, De Witte VAM. Liposomes for photodynamic therapy. Advanced Drug Delivery Reviews 2004; 56: 17–30
  • Dougherty TJ. Review: Photodynamic therapy. Journal of the National Cancer Institute 1998; 90: 889–905
  • Dunne M, Corrigan OI, Ramtoola Z. Influence of particle size and dissolution conditions on the degradation properties PLGA nanoparticles. Biomaterials 2000; 21: 1659–1668
  • Eaton DF. International union of pure and applied chemistry organic chemistry division commission on photochemistry. Reference materials for fluorescence measurements. Journal of Photochemistry & Photobiology B 1988; 60: 1107–1114
  • Eichwurzel I, Pevzener H, Roder B. Photophysical studies of the pheophorbide a dimer. Journal of Photochemistry & Photobiology B 2000; 54: 194–200
  • Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. Journal of Controlled Release 2001; 71: 53–69
  • Fisher AMR, Murphree AL, Gomer L. Clinical and preclinical photodynamic therapy. Laser in Surgery and Medicine 1958; 17: 2–31
  • Foote CS. Definition of type I and II photosensitized oxidation. Photochemistry and Photobiology 1991; 54: 659
  • Gantchev TG, Urumov IJ, Hunting DJ, Van Lier JE. Photocytotoxicity and intracellular generation of free radicals by tetrasulphonated Al and Zn phthalocyanine. International Journal of Radiation Biology 1994; 65: 289–298
  • Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Current Opinion in Solid State & Material Science 2002; 6: 319–327
  • He XY, Sikes RA, Thomsen S, Chung LW, Jacques SL. Photodynamic therapy with photofrin induces programmed cell death in carcinoma cell lines. Photochemistry & Photobiology 1994; 59: 468–473
  • Huang X, Brazel C. On the importance and mechanism of burst release in matrix controlled drug delivery system. Journal of Controlled Release 2001; 72: 121–136
  • Huo D, Deng S, Li L, Ji J. Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung targeting. International Journal of Pharmaceutics 2005; 289: 63–67
  • Jain R, Shah NH, Malick AW, Rodhes C. Controlled drug delivery by biodegradable poly(ester) devices deferent preparative approaches. Drug Developments in Industrial Pharmaceutics 1998; 24: 703–727
  • Jalón EJ, Blanco-Príeto MJ, Ygartua P, Santoyo S. Increased efficacy of acyclovir loaded microparticles against herpes simples virus type 1 in cell culture. European Journal of Pharmaceutics and Biopharmaceutics 2003; 56: 183–197
  • Kolárová H, Mosinger J, Lenobel R, Kejlova K, Jirová D, Strmad M. In vitro toxicity testing of supramolecular sensitizers for photodynamic therapy. Toxicology in vitro 2003; 17: 775–778
  • Konan YN, Berton M, Gurny R, Allemann E. Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl) porphyrin by incorporation into sub-200nm nanoparticles. European Journal of Pharmaceutical Sciences 2003; 18: 241–249
  • Konan YN, Gurny R, Allemann E. Invited review: State of art in the delivery of photosensitizer for photodynamic therapy. Journal of Photochemistry & Photobiology B: Biology 2002; 66: 89–106
  • Kwon H, Lee J, Choe S, Jang Y, Kim J. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2001; 182: 123–130
  • Lagarce F, Renaud P, Nicolas G, Richard J, Menei P, Benoit J. Baclofen loaded microspheres: Preparation and efficacy testing in a new rabbit model. European Journal of Pharmaceutics & Biopharmaceutics 2005; 59: 449–459
  • Leroux JC, Allemann E, Jaeghere F, Doelker E, Gurny R. Biodegradable nanoparticles from sustained formulation to improved site specific drug delivery. Journal of Controlled Release 1996; 39: 339–350
  • Madan PL. Sustained release drug delivery system: Part I an overtire. Pharmaceutical Manufacturing 1985; 48: 1–18
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983; 65: 55–63
  • Murakami D, Kobayashi M, Takeuchi H, Kawashima J. Preparation of poly(DL-lactide-co-glycolide) nanoparticle by modifier spontaneous emulsification solvent diffusion method. International Journal of Pharmaceutics 1999; 187: 143–152
  • Murakami D, Kobayashi M, Takeuchi H, Kawashima J. Further application of a modified spontaneous emulsification solvent diffusion method of various types of PLGA and PLA polymers for preparation of nanoparticle. Powder Technology 2000; 107: 137–143
  • Naraharisetti PK, Lew MDN, Fu Y, Lee D, Wang C. Gentamicin loaded discs and microspheres and their modifications: Characterization and in vitro release. Journal of Controlled Release 2005; 102: 345–359
  • Owens JW, Smith R, Robson R, Robins M. Photophysical properties of porphyrins, phthalocyanines and benzochlorins. Inorganic Chimica Acta 1998; 279: 226–231
  • Pinõn-Segundo E, Garnem-Quintanar A, Alonso-Perez V, Quintanar-Guerrerro D. Preparation and characterization of triclosan nanoparticles for periodontal treatment. International Journal of Pharmaceutics 2005; 294: 217–232
  • Quintanar-Guerrero D, Allemand E, Fessi H, Doelker E. Preparation techniques and mechanism of formation of biodegradable nanoparticle from performed polymers. Drug Developments in Industrial Pharmaceutics 1998; 24: 1113–1128
  • Reddi E, Lo Castro G, Biolo R, Jori G. Pharmacokinetic studies with zinc (II) phthalocyanines in tumor bearing mice. British Journal of Cancer 1987; 56: 597–600
  • Ricci EJ, Lunardi LO, Nanclaris DMA, Marchetti JM. Sustained release of lidocaine from Poloxamer 407 gels. International Journal of Pharmaceutics 2005; 288: 235–244
  • Rodal RG, Rodal SK, Moan J, Berg K. Liposome-bound Zn (II) phthalocyanine mechanism for cellular uptake and photosensitizer. Journal of Photochemistry & Photobiology B: Biology 1998; 45: 150–159
  • Saxena V, Sadoqi M, Shao J. Enhanced photo-stability, thermal-stability, and aqueous-stability of indocyanine green in polymeric nanoparticles systems. Journal of Photochemistry & Photobiology B: Biology 2004; 74: 29–38
  • Scholes PD, Coombes AGA, Illum L, Davis SS, Vert M, Davis MC. The preparation of sub-200 nm poly-(lactide-co-glycolide) microspheres for site-specific drug delivery. Journal of Controlled Release 1993; 25: 145–153
  • Sharman WM, Van Lier JE, Cynthia MA. Targeted photodynamic therapy via receptor mediated delivery systems. Advanced Drug Delivery Research 2004; 56: 53–76
  • Shenoy DB, Amiji MM. Poly (ethylene oxide)-modified poly(caproloctone) nanoparticles for target delivery of tamoxifen in bread cancer 2005, Article in press
  • Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy: A new concept in medical treatment. Brazilian Journal of Medical Biology Research 2000; 33: 869–880
  • Sibata MN, Tedesco AC, Marchetti JM. Photophysical and photochemical studies of Zinc (II) phthalocyanine in long time circulation micelles for photodynamic therapy use. European Journal of Pharmaceutical Sciences 2004; 23: 131–138
  • Soppimath KS, Aminabhaui TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticle as delivery devices. Journal of Controlled Release 2001; 70: 1–20
  • Stief TW. The physiology and pharmacology of singlet oxygen. Medical Hypotheses 2003; 60: 567–572
  • Teixeira M, Alonso MJ, Pinto MMM, Barbosa CM. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and e-methoxyxanthone. European Journal of Pharmaceutics & Biopharmaceutics 2005; 53: 491–500
  • Valduga G. Spectroscopic studies on Zn (II) phthalocyanine in homogeneous and microheterogeneous systems. Journal of Inorganic Biochemistry 1987; 29: 59–65
  • Van Nostrum CF. Polymeric micelles to deliver photosensitizer for photodynamic therapy. Advanced Drug Delivery Reviews 2004; 56: 9–16
  • Vistica DT. Tetrazolium based assay for cellular viability: A critical examination of selected parameters affecting formazan production. Cancer Research 1991; 51: 2515–2520
  • Washington C. Drug release from microdisperse systems. A critical review. International Journal of Pharmaceutics 1990; 58: 1–12
  • Zhou C, Shumji C, Jinsheng D, Junlin L, Jori G, Milanesi C. Apoptosis of mouse MS-2 fibrosarcoma cells induced by photodynamic therapy with Zn (II) phthalocyanine. Journal of Photochemistry & Photobiology B 1996; 33: 219–233

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.